Literature DB >> 20590637

Differential sensitivity of basal and acetylcholine-induced activity of nitric oxide to blockade by asymmetric dimethylarginine in the rat aorta.

Mohammed J Al-Zobaidy1, John Craig, William Martin.   

Abstract

BACKGROUND AND
PURPOSE: Previous work has shown that N(G)-monomethyl-l-arginine (l-NMMA) paradoxically inhibits basal, but not ACh-stimulated activity of nitric oxide in rat aorta. The aim of this study was to determine if the endogenously produced agent, asymmetric N(G), N(G)-dimethyl-l-arginine (ADMA), also exhibits this unusual selective blocking action. EXPERIMENTAL APPROACH: The effect of ADMA on basal nitric oxide activity was assessed by examining its ability to enhance phenylephrine (PE)-induced tone in endothelium-containing rings. Its effect on ACh-induced relaxation was assessed both in conditions where ADMA greatly enhanced PE tone and where tone was carefully matched with control tissues at a range of different levels. KEY
RESULTS: ADMA (100 microM) potentiated PE-induced contraction, consistent with inhibition of basal nitric oxide activity. Higher concentrations (300-1000 microM) had no greater effect. Although ADMA (100 microM) also appeared to block ACh-induced relaxation when it enhanced PE tone to maximal levels, virtually no block was seen at intermediate levels of tone in the presence of ADMA. Even ADMA at 1000 microM had no effect on the maximal relaxation to ACh, although it produced a small (two- to threefold) reduction in sensitivity. ADMA and l-NMMA, like l-arginine (all at 1000 microM), protected ACh-induced relaxation against blockade by l-NAME (30 microM). CONCLUSIONS AND IMPLICATIONS: In the rat aorta, ADMA, like l-NMMA, blocks basal activity of nitric oxide, but has little effect on that stimulated by ACh. Further studies are required to explain these seemingly anomalous actions of ADMA and l-NMMA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590637      PMCID: PMC2938818          DOI: 10.1111/j.1476-5381.2010.00802.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.

Authors:  P Vallance; J Collier; S Moncada
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

2.  Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.

Authors:  W Martin; R F Furchgott; G M Villani; D Jothianandan
Journal:  J Pharmacol Exp Ther       Date:  1986-05       Impact factor: 4.030

3.  Endothelial alpha 2-adrenoceptors in canine pulmonary and systemic blood vessels.

Authors:  V M Miller; P M Vanhoutte
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

4.  An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery.

Authors:  K A Dora; J M Hinton; S D Walker; C J Garland
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

5.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

7.  Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.

Authors:  T M Cocks; J A Angus
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

8.  Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia.

Authors:  L Vladimirova-Kitova; T Deneva; E Angelova; F Nikolov; B Marinov; N Mateva
Journal:  Clin Physiol Funct Imaging       Date:  2008-09-16       Impact factor: 2.273

9.  A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.

Authors:  D D Rees; R M Palmer; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

10.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

View more
  3 in total

1.  Characteristics of ACh-induced hyperpolarization and relaxation in rabbit jugular vein.

Authors:  Takeo Itoh; Takashi Maekawa; Yasushi Shibayama
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava.

Authors:  Joseph D Raffetto; Peng Yu; Ossama M Reslan; Yin Xia; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2011-12-30       Impact factor: 4.268

3.  Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.

Authors:  Gloria Segarra; Belén Cortina; María Dolores Mauricio; Susana Novella; Paloma Lluch; Javier Navarrete-Navarro; Inmaculada Noguera; Pascual Medina
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.